Multidisciplinary AI technologies and graph neural networks are integrated to construct a knowledge graph of drugs-targets-diseases, so as to mine new drug indications.

0 2- High-innovation Artificial Intelligence Platform for Mining New Disease Pathways

The intelligent contribution of professional drug research and development scientists " Design-Experiment-Optimization " cyclic iterative optimization.

0 3- High-level optimization platform of drug molecular design

Covering the full process of small molecule drug research and development, including virtual screening, structural design, fragment optimization, AI de novo drug generation, and molecular optimization.

0 4- High-intelligence Artificial Intelligence Small Molecule Drug Design Platform

World-leading generative artificial intelligence models to meet the research and development needs of various types of drugs, including antibodies, peptides, antibody-drug conjugates (ADCs), etc.

0 5- High-level Artificial Intelligence Macromolecular Drug Design Platform

AI-driven dynamic simulation and multimodal generation algorithms to meet the needs of molecular property prediction, molecular structure optimization, trimer modeling, etc.

0 6- High-performance Artificial Intelligence PROTAC Drug Design Platform

Based on the Directed Message Passing Neural Network (D-MPNN) technology to achieve rapid and accurate prediction of compound properties.

0 7- High-precision Artificial Intelligence Platform for Predicting ADMET Properties of Drugs